Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
NGM Biopharmaceuticals Inc banner
N

NGM Biopharmaceuticals Inc
F:0IK

Watchlist Manager
NGM Biopharmaceuticals Inc
F:0IK
Watchlist
Price: 3.22 EUR 0.94%
Market Cap: €268.7m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
Jun 30, 2025 251m
Dec 31, 2024 259.5m
Operating Income
+
Jun 30, 2025 15m
Dec 31, 2024 20.6m
Net Income
+
Jun 30, 2025 9.5m
Dec 31, 2024 11.7m

Earnings Waterfall
NGM Biopharmaceuticals Inc

Income Statement
NGM Biopharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2024 Jun-2025
Revenue
Interest Expense
1
0
Revenue
260
N/A
251
-3%
Gross Profit
Cost of Revenue
(196)
(189)
Gross Profit
63
N/A
62
-2%
Operating Income
Operating Expenses
(43)
(47)
Selling, General & Administrative
(20)
(26)
Research & Development
(12)
(17)
Depreciation & Amortization
(11)
(4)
Operating Income
21
N/A
15
-27%
Pre-Tax Income
Interest Income Expense
(0)
(3)
Non-Reccuring Items
(3)
(1)
Total Other Income
(1)
0
Pre-Tax Income
16
N/A
12
-28%
Net Income
Tax Provision
(5)
(2)
Income from Continuing Operations
12
10
Net Income (Common)
12
N/A
10
-19%
EPS (Diluted)
0.06
N/A
0.05
-17%

See Also

Summary
0IK intrinsic value, competitors valuation, and company profile.
DCF Valuation
0IK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0IK stock valuation using valuation multiples.
Wall Street Estimates
0IK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0IK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.